NF2 and cancer: NF2 is the most commonly mutated Hippo pathway component in cancers, and NF2 loss‐of‐function mutations are especially prevalent in pleural mesothelioma (Moroishi et al, 2015a; Petrilli & Fernandez‐Valle, 2016).